DNA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	71.16M
Średni wolumen	26.69M
Kapitalizacja rynkowa	1.85B
EPS	$0 ( 2024-02-29 )
Następna data zysków	( $-0.0800 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.870
ATR14	$0.00300 (0.35%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Dmytruk Mark E.	Sell	22 916	Restricted Stock Units
2024-04-01	Dmytruk Mark E.	Buy	1 634	Class A Common Stock
2024-04-01	Dmytruk Mark E.	Buy	22 916	Class A Common Stock
2024-04-01	Dmytruk Mark E.	Buy	18 125	Class A Common Stock
2024-04-01	Dmytruk Mark E.	Buy	65 448	Class A Common Stock

INSIDER POWER
-25.19
Last 100 transactions
Buy: 2 333 675 \| Sell: 4 285 014

Wolumen Korelacja

Długi: 0.42 (neutral)

Krótki: -0.66 (moderate negative)

Signal:(60.156) Neutral

Ginkgo Bioworks Holdings, Korelacja

10 Najbardziej pozytywne korelacje
ATTO	0.927
KT	0.92
DHX	0.918
ARMK	0.912
WF	0.911
PDS	0.911
WRBY	0.902
MYTE	0.902
AVYA	0.899
AMRC	0.899

10 Najbardziej negatywne korelacje
RXN	-0.884
MOG-B	-0.881
DSE	-0.872
COR	-0.872
MSP	-0.87
PSXP	-0.868
AMAM	-0.864
TNK	-0.855
CMO	-0.851
FPAC	-0.851

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ginkgo Bioworks Holdings, Korelacja - Waluta/Towar

0.00
( neutral )

0.52
( weak )

Ginkgo Bioworks Holdings, Finanse

Annual	2023
Przychody:	$251.46M
Zysk brutto:	$142.64M (56.73 %)
EPS:	$-0.460

FY	2023
Przychody:	$251.46M
Zysk brutto:	$142.64M (56.73 %)
EPS:	$-0.460

FY	2022
Przychody:	$477.71M
Zysk brutto:	$273.49M (57.25 %)
EPS:	$-1.250

FY	2021
Przychody:	$313.84M
Zysk brutto:	$204.16M (65.05 %)
EPS:	$-1.231

Financial Reports:

No articles found.

Ginkgo Bioworks Holdings,

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.